The breakpoint junction sequences revealed an insertion of two nucleotides at the MLL-AFF1 junction.     ///    This study further supports the evidence that MLL breakpoints in therapy-related acute leukemia with MLL-AFF1 are clustered in the telomeric half of the breakpoint cluster region that contains topo II recognition sites.. 